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Dear Editor,
I read with great interest the recent article by Lima et al., 1
Crohn’s disease may be associated with signiﬁcant psychiatric
illnesses.
An incidence rate of depression as high as 32% has
been reported in patients with underlying Crohn’s disease.2
Higher degrees of depression are observed in patients with
a poor quality of life. Younger individuals with underly-
ing Crohn’s disease are almost 2.75 times more  likely to
develop persistent depression.3 Similarly, patients with low
economic status tend to develop a more  severe degree of
depression.4 Individuals with extra-intestinal involvement,
such as joint involvement, also tend to report higher degrees of
depression.
A similar association is observed with the devel-
opment of anxiety in Crohn’s disease patients. Nearly
24% of them develop anxiety.3 In a recent study, Lof-
tus et al. showed that younger patients with underly-
ing Crohn’s disease are almost 4.35 times more  likely
to develop persistent anxiety. 3 Certain therapies, such
as inﬂiximab, actually worsen the anxiety. Crohn’s dis-
ease patients also report high degrees of fatigue, which
may be exacerbated by the development of concurrent
depression.5
Similarly, patients may present with isolated bipolar
disorder.6 Treatment with steroids especially predisposes
Crohn’s disease patients to manic episodes. Holroyd et al., in a
recent study, reported that nearly 57% of patients with Crohn’s
disease who developed a manic episode had received recent
prednisone therapy.7
The above examples clearly highlight the signiﬁcant psy-
chiatric co-morbidity of Crohn’s disease and the need to
address these as soon as possible after the diagnosis is
made. e  f  e  r  e  n  c  e s
. Lima FD, Ribeiro TC, Chebli LA, Pace FH, Chaves LD, Ribeiro MS,
et  al. Mood swings in patients with Crohn’s disease: incidence
and  associated factors. Rev Assoc Med  Bras. 2012;58:481–8.
.  Cho OH, Yoo YS, Yang SK. Depression and risk factors in
patients with Crohn’s disease. J Korean Acad Nurs.
2012;42:207–16.
. Loftus Jr EV, Guerin A, Yu AP, Wu  EQ, Yang M, Chao J, et al.
Increased risks of developing anxiety and depression in young
patients with Crohn’s disease. Am J Gastroenterol.
2011;106:1670–7.
. Moradkhani A, Beckman LJ, Tabibian JH. Health-related quality
of  life in inﬂammatory bowel disease: psychosocial, clinical,
socioeconomic, and demographic predictors. J Crohns Colitis.
2012 [Epub ahead of print].
. Jelsness-Jorgensen LP, Bernklev T, Henriksen M,  Torp R, Moum
B.  Chronic fatigue is associated with increased disease-related
worries and concerns in inﬂammatory bowel disease. World J
Gastroenterol. 2012;18:445–52.
. Kalach N, Vicent G, Ginisty D, Barbet P, Cosnes J, Dupont C.
Isolated bipolar presentation of Crohn’s disease in a child. J
Pediatr Gastroenterol Nutr. 2001;32:86–8.
. Holroyd S, DePaulo Jr JR. Bipolar disorder and Crohn’s disease. J
Clin Psychiatry. 1990;51:407–9.
Shailendra Kapoor ∗
Mechanicsville, VA, USA
∗ 74 Crossing Place, Mechanicsville, VA, USA.
E-mail: shailendrakapoor@yahoo.comhttp://dx.doi.org/10.1016/j.ramb.2013.01.006
